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Regulation of gene expression at the level of protein synthesis is a
crucial element in driving how the genetic landscape is expressed.
However, we are still limited in technologies that can quantitatively
capture the immediate proteomic changes that allow cells to
respond to specific stimuli. Here, we present a method to capture
and identify nascent proteomes in situ across different cell types
without disturbing normal growth conditions, using O-propargyl-
puromycin (OPP). Cell-permeable OPP rapidly labels nascent elon-
gating polypeptides, which are subsequently conjugated to biotin-
azide, using click chemistry, and captured with streptavidin beads,
followed by digestion and analysis, using liquid chromatography–
tandem mass spectrometry. Our technique of OPP-mediated identi-
fication (OPP-ID) allows detection of widespread proteomic changes
within a short 2-hour pulse of OPP. We illustrate our technique by
recapitulating alterations of proteomic networks induced by a po-
tent mammalian target of rapamycin inhibitor, MLN128. In addition,
by employing OPP-ID, we identify more than 2,100 proteins and
uncover distinct protein networks underlying early erythroid pro-
genitor and differentiation states not amenable to alternative ap-
proaches such as amino acid analog labeling. We present OPP-ID as
a method to quantitatively identify nascent proteomes across an
array of biological contexts while preserving the subtleties directing
signaling in the native cellular environment.
proteomics | translation | mTOR | erythropoiesis | puromycin
Understanding how cells swiftly direct gene expression inresponse to a myriad of environmental signals remains a poorly
understood question. Despite advances in transcriptome analysis,
transcript composition is an inaccurate surrogate for protein abun-
dance (1) and argues for a need to comprehensively analyze gene
expression at the proteomic level (2). Recent studies have uncovered
translational control as a key determinant of protein abundance (3).
However, quantitatively capturing de novo proteomic programs in
primary cells undergoing differentiation in situ remains challenging.
Methods have evolved to quantify nascent proteomic changes
in response to environmental cues. Stable isotope-labeled amino
acids (4–7), bioorthogonal noncanonical amino acid tagging
(BONCAT) [L-azidohomoalanine or homopropargylglycine
(HPG) labeling] (8–13) or their combination (13) have been
used to quantitatively identify nascent proteomes and visualize
global protein synthesis in situ (14, 15). However, these methods
are dependent on alteration of amino acids from cellular media,
which imposes challenges on analysis of primary cell models of
differentiation with fastidious, multistep media requirements.
Puromycin-associated nascent chain proteomics (PUNCH-P)
obviates the need for using specific growth conditions by labeling
harvested ribosomes from sucrose-gradient polysome fractions
with biotinylated puromycin (16). However, this technique may
miss subtleties in dynamics of protein synthesis occurring
uniquely within the actual cellular context.
To overcome these barriers, we set out to design a protocol that
would allow identification and quantitative assessment of nascent
proteomes in a short incubation time, be applicable irrespective of
cellular background or culture conditions, and efficiently label
proteomes to permit identification of proteomic alterations in situ.
We took advantage of an analog of puromycin containing a terminal
alkyne group, known as O-propargyl-puromycin (OPP) (17). As a
tyrosine-tRNA mimetic, OPP can be catalytically incorporated by
the ribosome into the C terminus of nascent polypeptide chains
during elongation, which results in premature termination of trans-
lation and release of C-terminally truncated polypeptides bearing
OPP. The alkyne group thus installed on nascent polypeptides can be
conjugated to an array of biosensors, using copper(I)-catalyzed azide-
alkyne cycloaddition (click chemistry), and has been used extensively
to study dynamic changes in global translation both in vitro and in vivo
(18–23). The combination of high cell permeability and signal-to-noise
ratio makes OPP an ideal candidate compound to study nascent
proteomes across a wide array of cellular types and conditions.
Significance
Deciphering which networks of genes allow cells to rapidly
respond to environmental cues is key to understanding pro-
cesses such as proliferation, differentiation, and death. Here,
we describe a technique to quantitatively identify nascent
protein synthesis using O-propargyl-puromycin (OPP), a specific
covalent label of growing polypeptides, which are then iso-
lated and measured by mass spectrometry. This technique,
named OPP-mediated identification (OPP-ID), is applicable across
a wide array of cell types for identification of proteins in situ.
We illustrate the capability of OPP-ID by identifying a constel-
lation of mammalian target of rapamycin (mTOR)-dependent
gene networks and uncovering an array of genes involved in
early erythroid progenitor expansion. OPP-ID is a powerful tech-
nique to study how cells modulate nascent protein expression to
respond to stresses and stimuli.
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We wish to report a method for identifying and quantifying
newly synthesized proteins, which we have termed OPP-ID (Fig. 1).
In this approach, nascent polypeptides tagged with OPP are conju-
gated with biotin-azide and enriched using streptavidin beads.
Immobilized samples are then subjected to on-bead digestion with
trypsin, and the digests are analyzed by liquid chromatography with
tandem mass spectrometry (LC-MS/MS) to both identify and enable
label-free quantification of nascent proteins. We show that OPP is
robustly incorporated into a wide array of protein sizes and provides
comparable coverage to BONCAT-based HPG methods. OPP-ID
allows comprehensive and quantitative identification of nascent pro-
teins in native cellular contexts, thus expanding our capability to study
rapid changes in translation employed by cells to respond to stimuli
such as pharmacologic perturbation or cellular differentiation.
Results
Development of a method to quantify nascent protein abundance
using OPP necessitated initial optimization of dosage and labeling
time interval. Our goal was to identify a concentration and time
pulse of OPP, which would allow observation of a maximal molec-
ular weight diversity and fluorescence intensity of labeled proteins.
K562 cells were pulsed with increasing concentrations of OPP over
the course of 1 or 2 h. OPP-labeled polypeptides from cell lysates
were conjugated to tetramethylrhodamine (TAMRA)-azide by cy-
cloaddition, and fluorescence intensity was measured on equivalent
total protein loading of SDS/PAGE-resolved gels. We observed a
dose-dependent increase in fluorescence with a maximal intensity
and protein size distribution when OPP was pulsed over the course
of 2 h (Fig. S1A). The maximal duration of 2 h was chosen because
prior results have shown decreased OPP labeling at 3 h of treatment
(17). This label is specific to protein synthesis, as the fluorescent
signal could be reduced to nonlabeled background levels with the
inhibitor cycloheximide (Fig. S1A). The highest concentration of
OPP used was 30 μM, which was well below published labeling
doses (17) and had no effect on cell viability or markers of cellular
stress, including PARP or caspase 3 cleavage or reactive oxygen
species (ROS) generation (Fig. S2). We next asked whether our
labeling strategy detected nascent protein synthesis at comparable
levels as previously described methods employing the amino acid
analog HPG. HPG-labeled proteins showed overall higher fluores-
cence than OPP-labeled proteins, especially for large molecular
weight proteins (Fig. 2A and Fig. S1A).
To determine whether OPP labeling could isolate polypep-
tides of comparable length, protein coverage, and relative
abundance to HPG-mediated labeling, we analyzed tryptic pep-
tides obtained from HPG- or OPP-labeled proteins by LC-MS/
MS (Dataset S1). Interestingly, comparison of the percentage of
identified proteins across a distribution of polypeptide lengths
did not show a pronounced difference between HPG and our
maximal OPP dose of 30 μM (Fig. S1B). This result implies that
despite the polypeptide chain terminator property of OPP, we
are still able to identify proteins of a wide array of polypeptide
sizes. We identified the highest number of proteins in the OPP-
labeled cells, representing a 1.6× increase over HPG (535 in
OPP vs. 335 in HPG) in unique proteins not found in the DMSO
background dataset (Fig. 2B and Dataset S1). In addition, peptide
sequence coverage of proteins identified was also augmented in an
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Fig. 1. OPP-ID as a tool to identify nascent protein synthesis: By mimicking tyrosine-tRNA, OPP binds to the acceptor (A) site of the ribosome during
elongation and leads to subsequent polypeptide chain termination instead of extension of the polypeptide through the peptidyl (P) site and release of tRNA
at the exit (E) site. The alkyne group on OPP is conjugated to an azide group on biotin using cycloaddition. Biotin–polypeptide complexes are bound to
streptavidin beads followed by on-bead digestion and analysis by LC-MS/MS for identification and quantification.
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Fig. 2. OPP labels nascent proteomes with comparable coverage, peptide
intensity, and identification to HPG. (A) TAMRA-conjugated proteins labeled
by specified concentrations of HPG or OPP in comparison with DMSO vehicle
were isolated by SDS/PAGE and analyzed by fluorescence scan at 532 nm.
Denoted box indicates overlaid image of molecular weight ladder captured
at 647 nm. Representative section of Coomassie-stained gel for loading
comparison. (B) Venn diagram of identified proteins in HPG 25 μM or OPP
30 μM after subtraction of overlapping proteins identified in DMSO vehicle.
(C) Proteins identified in all labeling schemes were aligned, and mean per-
centage peptide coverage with 95% confidence interval plotted. ***P < 0.001;
****P < 0.0001. (D) Proteins identified in all labeling schemes were aligned and
mean intensity (summed extracted ion chromatograms represented as arbi-
trary units) 95% confidence interval displayed. **P < 0.01; ****P < 0.0001.
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OPP dose-dependent manner to above that of HPG (Fig. 2C).
Finally, to determine whether OPP labeling could be used to as-
certain quantitative abundance of identified proteins, the relative
abundance of identified proteins was calculated from the sum of
the individual unique peptide intensities extracted ion chromato-
grams. We found that abundance per protein is also increased in
an OPP dose-dependent manner, achieving levels above that of
HPG (Fig. 2D). In summary, our method using 30 μM OPP can
identify nascent polypeptides in cultured cells with comparable
distribution of molecular weight, along with higher protein se-
quence coverage and abundance compared with that of HPG at
25 μM, without the necessity of employing specialized, amino acid-
depleted media.
To demonstrate the utility of our technique, we asked whether
OPP-ID could identify nascent proteomic changes on pharma-
cologic inhibition of the mammalian target of rapamycin
(mTOR). mTOR is a key kinase downstream of several cues that
acts as a hub to shape the cellular proteome to direct distinct
molecular and cellular processes, including protein synthesis and
cell growth (24, 25). Potent, specific ATP-binding site inhibitors
of mTOR have been developed and extensively studied for their
effect on gene expression (26–28), making these drugs ideal
candidates to validate the specificity of OPP-ID in identifying
nascent proteomes. To study proteomic output in the context of
mTOR inhibition, we first pretreated K562 cells for 1 h with
either vehicle or MLN128, an ATP-binding site inhibitor with 10-
fold more potency than first-generation ATP-site inhibitors such
as PP242 (28, 29). We then pulse-labeled with either vehicle or
OPP for 2 h and collected cell pellets for lysis and analysis (Fig. 3A).
Analysis of lysates showed a sensitive and specific OPP in-
corporation across an array of protein molecular weights with
minimal decrease in global signal from the MLN128 treatment (Fig.
3B and Fig. S2D). Labeled protein was reacted with biotin-azide,
conjugated to streptavidin beads, digested with trypsin, and ana-
lyzed using LC-MS/MS with CID on an LTQ Orbitrap Velos mass
spectrometer. The experiment was performed in triplicate, and
1,001 proteins were quantified, with the majority seen in the OPP-
labeled conditions (Fig. S3A). Proteins isolated from conditions
without OPP were stringently removed, and nascent proteins from
OPP-labeled conditions were further filtered to a total of 217 OPP-
specific labeled nascent proteins (Fig. S3A). We validated efficacy
of our MLN128-mediated mTOR repression by measuring re-
duction in phosphorylation of known downstream mTOR effectors
4EBP1, S6K, and rpS6 (Fig. S3B). To further evaluate whether our
filtering strategy removed isolated proteins that were not specifically
OPP-labeled, we used datasets contained in the Contaminant Re-
pository for Affinity Purification (CRAPome) (30). We aligned our
identified proteins with background contaminants from human cell
experiments employing a similar streptavidin-based pull-down
strategy (referred to here as the SA-CRAPome; Dataset S2). We
considered proteins occurring in greater than 30% of the pull-down
experiments in the SA-CRAPome as background in our experi-
ment. Our filtering strategy effectively removed 84.4% of such
background proteins (Dataset S2), confirming that our exclusion
and inclusion criteria could specifically isolate OPP-labeled nascent
proteomes. OPP-labeled cells showed a robust difference in the
number of identified proteins across a broad distribution of peptide
intensities over background conditions (Fig. 3C). Comparison of
fold change of protein intensity demonstrated an array of de novo
proteins inhibited by MLN128 at varying degrees (Fig. 3D). We
identified 52 proteins with more than twofold repression of nascent
proteins in MLN128-treated cells (Fig. 3E and Dataset S2). Proteins
were further analyzed for statistical significance in up-regulation or
repression in the presence of MLN128 (Fig. S3C and Dataset S2).
DAVID Gene ontology analysis of proteins repressed by
MLN128 strongly enriches for GO biological processes including
nonsense-mediated decay, SRP protein targeting, translation initi-
ation, and rRNA processing (Fig. S3D). Highly enriched categories
of nascent proteomes inhibited by mTOR ATP site inhibitors
showed strong conservation between OPP-ID and ribosome pro-
filing-mediated experiments (28) (Fig. S3E). Western blot vali-
dation of MLN128-repressed targets of varying P values from the
OPP-ID dataset showed differential levels of protein reduction
with MLN128 (Fig. 3F) (31). Interestingly, qPCR of mRNA from
MLN128-treated K562 cells does not implicate transcription as a
mechanism for repression of specific nascent protein synthesis in
these targets (Fig. S3F). This highlights an important concept that
viewing gene expression strictly at the level of transcription neglects
the contribution of de novo protein synthesis.
We next asked whether OPP-ID could be applied to decipher
nascent proteomic changes in a model of physiologic cellular
differentiation. Extensively self-renewing erythroblast (ESRE)
cells are a murine yolk sac-derived cell system capable of re-
capitulating all phases of erythropoiesis (32–34). ESRE cells can
expand in a progenitor state (predominantly proerythroblasts
and basophilic erythroblasts), using a complex serum-free media
containing an array of cytokines and growth factors known
as expansion media. However, switching to maturation media
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Fig. 3. OPP-ID identifies a specific nascent proteome repressed by an active-
site mTOR inhibitor. (A) Schematic for K562 cell-based analysis of the
MLN128-repressed nascent proteome. (B) Cell lysates from culture conditions
were analyzed for TAMRA-azide conjugated OPP proteins by SDS/PAGE with
fluorescence detection at 532 nm. Denoted box indicates overlaid image of
molecular weight ladder captured at 647 nm. Coomassie staining of gel for
total protein loading shown adjacent to fluorescence image. (C) Plot of
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(log2) of nascent protein abundance in DMSO vehicle vs. MLN128-treated
cells per individual protein. Dotted line denotes cutoff of log2 FC > 1.
(E) Fold change analysis between DMSO vs. MLN128 subdivided into groups
of log2 FC. (F) Western blot verification of OPP-ID identified nascent pro-
teins with densitometric reduction normalized to beta-actin.
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induces terminal differentiation of erythroblasts over the course
of 3 d to mature erythrocytes. Complex media requirements of
this system present challenges to the use of strategies such as
stable isotope-labeled amino acids or amino acid analogs. We
used OPP-ID to interrogate the earliest nascent proteomic
changes unique to growth conditions that maintain early erythroid
precursors in comparison with conditions promoting maturation.
ESRE cells were grown in expansion media, washed, and replated
in either expansion or maturation media, followed by pulse labeling
with either OPP or PBS vehicle (Fig. 4A). Protein lysates were
processed as in prior experiments, but samples were run on a Q
Exactive Plus hybrid quadrupole-orbitrap mass spectrometer with
increased sensitivity, enabling quantification of 2,194 individual
proteins (Fig. S4A) with minimal variance between replicates in
MS1 intensity (Fig. S5). After background filtering, 290 OPP-la-
beled, nascently synthesized proteins were obtained (Fig. S4A and
Dataset S3). After filtering proteins nonspecific to OPP-labeling,
our filtering strategy removed 97.3% of mouse orthologs of our
SA-CRAPome background proteins (Dataset S3). Within the first
3 h of switching growth conditions, expansion media promotes
synthesis of 142 unique proteins, whereas maturation media directs
synthesis of 28 unique proteins (Fig. 4 B and C). OPP-ID labeling
enables LC-MS/MS-identified peptides spanning deeply across
protein sequences, as shown for Ddx18, a protein promoted by
expansion media (Fig. S6). Closer analysis of proteins uniquely
synthesized in expansion media clusters processes of mRNA
splicing, processing, export, and unwinding of secondary structure
(Fig. S4B). Within these categories, known mediators of hemato-
poietic maintenance, expansion, and aging including Ddx18 (35),
Cdk9 (36), Cdk6 (37), Stag2 (38), Thoc1 (39), Xab2 (40), and
Pold1 (41) were observed (Fig. 4D). Identification of known reg-
ulators of early hematopoiesis lends credence to OPP-ID as a
methodology to probe nascent proteomic programs and a platform
to discover novel targets of complex biological processes.
Discussion
In this work, we describe a robust proteomic strategy to analyze
newly synthesized proteins in situ. Our method is based on use of
an alkyne derivative of puromycin to capture nascent proteins
and mass spectrometry to establish their identity and relative
amounts. Having the ability to interrogate rapid changes in gene
expression networks at the protein level provides an extremely
powerful tool to characterize the early cell decisions downstream
of specific stimuli.
Interestingly, we observed higher fluorescence signal from HPG-
labeled than from OPP-labeled proteins (Fig. 2A). This may be a
result of a combination of favorable HPG incorporation in me-
thionine-depleted media and the fact that HPG can potentially
incorporate at multiple sites of a newly synthesized protein. On the
contrary, OPP, as a chain terminator, can only incorporate a single
label per polypeptide, which leads to lower in-gel fluorescence
signal. Despite this, our OPP results show robust proteome labeling
coverage with minimal perturbation of normal growth conditions
in which amino acid analog labeling would not be feasible.
Strikingly, OPP-ID identified nascent proteins encoded by dis-
tinct categories of mRNA downstream of mTOR inhibition pre-
viously observed by prior ribosome profiling-mediated approaches
(27, 28). However, the number of genes identified in each category
was wider in ribosomal profiling. This is not surprising because of
differences in cell types, slight difference in inhibitors, and the
stringency in filtering protein identifications performed here.
Overall, conservation of functional categories is a testament to the
power of OPP-ID as an invaluable tool to directly measure dif-
ferences between ribosomal occupancy and proteomic output.
Another strong advantage of techniques such as OPP-ID is
that proteins with high stability may not have marked changes in
abundance in response to stimuli when visualized by Western
blot. Important effects on de novo synthesis of proteins with
longer half-lives may be missed without techniques such as OPP-
ID to detect subtle, yet important, proteomic changes (42).
The ability to interrogate rapid changes in gene expression at
the level of protein production opens a window into how the
cellular proteome responds to cues directing cell fates such as
proliferation and differentiation. A paradigm example is eryth-
ropoiesis, which is dependent on an intricate balance of main-
taining erythroid precursors and rapid differentiation to
accommodate hematopoietic stresses. In this study, we employed
ESRE cells to define the earliest proteomic programs unique to
the decision between expanding erythroid precursors and ter-
minal maturation. A major alteration in ESRE culture media
between expansion and maturation media is the withdrawal of
dexamethasone. How dexamethasone, a synthetic glucocorticoid
crucial in in vitro expansion of erythroid precursors (32, 33, 43)
and rescue of failed erythropoiesis in red cell aplasia disorders
such as Diamond Blackfan Anemia (44–47), directs erythropoi-
esis at the proteomic level is still largely unknown. Using OPP-
ID, we discovered a network of genes involved in splicing,
nucleic acid secondary structure unwinding, and cell cycle reg-
ulation that are rapidly repressed in the absence of dexametha-
sone. Although we observed genes previously known to be
associated with early hematopoietic precursor states (such as
Ddx18, Stag2, and Pold1), we also identified multiple genes such
as Prpf6, Sart1, Psen2, and Mycbp2, which have not been pre-
viously implicated in erythropoiesis. In future studies, it will be
intriguing to decipher how these factors maintain early erythroid
precursors and how dexamethasone supports their expression.
Given the ability of OPP to rapidly incorporate into multiple
tissues in vivo after i.p. injection (17), OPP-ID has the potential
to ask innumerable questions on dynamic proteomic networks at
the organismal level. Combining the universal applicability of
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OPP-ID with other next-generation techniques such as RNAseq
or ribosome profiling will create a powerful toolbox to study early
cellular events in signal transduction, differentiation, and oncogenesis.
Materials and Methods
Cell Culture. K562 cells were cultured in RPMI media 1640-GlutaMax (Gibco)
supplemented with 10% FBS (Axenia BioLogix), 100 U/mL penicillin, and
100 μg/mL streptomycin. HPG experiments were performed using methio-
nine-free RPMI (Invitrogen) with the supplementation listed here and 25 μM
HPG (Invitrogen). ESRE cells were cultured as previously described (33).
Briefly, ESREs were expanded in expansion media consisting of StemSpan SFE
(Stem Cell Technologies), 100 U/mL penicillin, 100 μg/mL streptomycin, 2 U/mL
erythropoietin (Peprotech), 100 ng/mL stem cell factor (SCF) (Peprotech), 1 ×
10−6 M dexamethasone (Sigma), 40 ng/mL IGF1 (Stem Cell Technologies), and
0.4% ExCyte (Millipore) grown on gelatin-coated tissue culture dishes. Matu-
ration of ESREs was driven by washing cells and switching media to matura-
tion media consisting of 1× Iscove’s modified Dulbecco’s medium (IMDM),
2 U/mL erythropoietin, 100 ng/mL SCF, 10% serum replacement (Invitrogen), 5%
plasma-derived serum (PDS) (Animal Technologies), 1× glutamine, 10% protein-
free hybridoma medium (PFHM)-II (Gibco) and 12.7 μL/100 mL of 1:10 MTG
(Sigma). Culture density was kept <2 × 106/mL. All cells were maintained in a
humidified 37 °C incubator with 5% CO2.
Treatment of Cells with Probes and Preparation of Cell Lysates. For labeling
experiments, K562 or ESRE cells were cultured to a density of 1.2 × 106/mL in a
total of 20 mL media. In the OPP dose titration experiment, cells were
treated directly with 3–30 μM OPP (MedChem) for 1 or 2 h in the full me-
dium at 37 °C. For labeling of mTOR-dependent nascent proteomes,
K562 cells were cultured with either DMSO vehicle or MLN128 (300 nM) for
1 h. For labeling of nascent maturation proteomes, ESRE cells were cultured
with either expansion or maturation media (see earlier) for 1 h. Cultures
were then treated with either PBS or OPP (30 μM) for 2 h with intermittent
gentle agitation. After treatment, cells were collected by centrifugation at
300 × g at 4 °C and then resuspended in lysis buffer containing 100 mM
Hepes at pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 2 mM PMSF, and 1×
complete EDTA-free protease inhibitor mixture (Roche). Cellular debris was
removed by centrifugation at 16,000 × g for 30 min at 4 °C. Protein con-
centration was determined by the BCA assay (Bio-Rad). Cell lysates were
diluted with lysis buffer to give a final protein concentration of 1.8 mg/mL
(1.2 mL total volume) or 1.6 mg/mL (0.4 mL total volume) for the K562 or
ESRE cells, respectively, for the subsequent Cu(I)-catalyzed click reactions.
Portions of the samples to be reacted with biotin-azide for affinity purifi-
cation were precleared by overnight incubation with high-capacity strepta-
vidin agarose resin (Thermo Scientific) at 4 °C with slow rotation.
Click Conjugation with TAMRA-Azide or Biotin-Azide. For click chemistry, a
reagent mix was freshly prepared by sequential addition of stock solutions to
achieve 6.25% SDS, 0.625 mM TAMRA-azide, or biotin-azide (Thermo Sci-
entific), 6.25 mM TCEP (Sigma), 0.625 mM TBTA (Sigma), and 6.25 mM CuSO4.
Appropriate volumes of reagent mix were then delivered to lysates (1:5.25,
vol/vol) to achieve 1% SDS, 100 μM TAMRA-azide or biotin-azide, 1 mM
TCEP, 100 μM TBTA, and 1 mM CuSO4. Typically, 42 μL lysate was reacted for
fluorescence visualization and 0.4–1.0 mL for affinity purification. After 1.5 h
at room temperature, reactions were quenched as described here.
In-Gel Fluorescence Visualization. After click conjugation with TAMRA-azide,
15 μL samples were treated with 4× Laemmli sample buffer and resolved by
SDS/PAGE. Gels were scanned for fluorescently labeled proteins using exci-
tation wavelength 532 nm, and also for the molecular weight marker, using
excitation wavelength 647 nm (Typhoon Imaging System; Molecular Dy-
namics), then stained with Coomassie blue reagent.
Streptavidin Affinity Enrichment of Biotinylated Proteins. After click conju-
gation with biotin-azide, samples were mixed with 5 volumes cold acetone
and stored overnight (−20 °C). Precipitated proteins were pelleted by cen-
trifugation at 3,500 × g at 4 °C for 5 min and washed twice with 2 mL cold
methanol. Protein pellets were resuspended in 120 μL PBS containing 1%
SDS and desalted by passing through Zeba spin 0.5 mL 7K cutoff desalting
columns (Thermo Scientific) equilibrated with 1% Nonidet P-40, 0.1% SDS in
PBS. Protein concentrations were measured (BCA assay) and normalized to
the lowest concentration by dilution with the elution buffer. Labeled pro-
teins (typically in 80 μL total volume) were then immobilized with magnetic
streptavidin beads (typically from 80 μL slurry; Pierce) at 4 °C overnight with
slow rotation. Beads were washed twice with 0.5 mL 1% Nonidet P-40, 0.1%
SDS in PBS for 10 min, three times with 0.5 mL ice-cold 6 M urea in PBS for
15 min, and three times with 0.5 mL ice-cold PBS for 10 min, all at 4 °C with
slow rotation. Finally, beads were rinsed with buffer containing 20 mM
Tris·HCl at pH 8.0 and 2 mM CaCl2.
On-Bead Trypsin Digestion of Pull-Down Products. Proteins immobilized on
magnetic streptavidin beads were suspended in trypsinization buffer (20 mM
Tris·HCl at pH 8.0 and 2 mM CaCl2). Samples were treated with 5 mM DTT at
56 °C for 30 min, followed by alkylation with 20 mM iodoacetamide at room
temperature for 30 min in the dark. Samples were treated once more with
5 mM DTT (5 min), followed by incubation with 500 ng sequencing grade
trypsin (Promega) overnight at 37 °C on a shaking incubator. Digestion was
stopped by adding 1% formic acid. The resulting peptides were enriched
with C18 Omix Tips (Agilent Technologies) and eluted with 50% acetonitrile
containing 0.1% formic acid. The samples were dried down by SpeedVac and
then resuspended in 0.1% formic acid for analysis by LC-MS/MS.
LC-MS/MS Analysis. Peptides resulting from trypsinization were analyzed on
an LTQ-Orbitrap Velos or a Q Exactive Plus hybrid quadrupole-orbitrap mass
spectrometer (both from Thermo Fisher Scientific) connected to a Nano-
Acquity Ultra Performance UPLC system (Waters). An EASY-Spray PepMap
RSLC C18, 3 μm, 75 μm × 15 cm column (Thermo Scientific) was used to re-
solve peptides using a binary solvent system consisting of 0.1% formic acid in
water as mobile phase A and 0.1% formic acid in acetonitrile as mobile
phase B. With the LTQ-Orbitrap Velos, typical 90-min gradients were as
follows: load at 2% B at 600 nL/min for 18 min, reduce flow rate to 300 nL/
min over 2 min, gradient from 2 to 30% B over 57 min, increase to 50% B
over 2 min, decrease to 2% B over 2 min, and equilibrate at 2% B for 9 min.
Slightly different elution conditions were used on the Q Exactive Plus: load
at 2% B at 600 nL/min for 15 min, reduce flow to 400 nL/min, gradient from
2 to 25% B over 48 min, increase to 37% B over 6 min, increase to 40% B
over 3 min, elute with 40–80% B over 3 min, decrease to 2% B over 3 min,
and equilibrate to 2% B over 13 min. Both mass spectrometers were oper-
ated in the data-dependent mode to automatically switch between MS and
MS/MS. On the LTQ-Orbitrap Velos (full MS resolution, 30,000), the top six
precursor ions with a charge state of 2+ or higher were selected with an
isolation width of 3.0m/z and fragmented by CID, using a dynamic exclusion
time of 60.0 s. On the Q Exactive Plus (full MS resolution, 70,000), the top
10 precursor ions with a charge state of 2+ or higher were selected with an
isolation width of 4.0 m/z and fragmented by HCD (resolution, 17,500), with a
15.0 s dynamic exclusion time. Using Protein Prospector (48) (v 5.19.1), all peak
lists from LC-MS/MS runs in a given experiment were searched in combination
against the appropriate SwissProt database (2015.12.1), either human (20,194/
549,832 entries searched) or mouse (16,740/549,832 entries searched), con-
catenated with a corresponding random decoy database to allow for FDR
determinations. The database search was performed with the following pa-
rameters: a mass tolerance of 20 ppm for precursor masses, ±0.8 Da for MS/MS
fragment ions on the LTQ-Orbitrap Velos or 30 ppm for MS/MS fragment ions
on the Q Exactive Plus, cysteine carbamidomethylation as a fixed modification,
and several common variable modifications (including acetylation of protein N
termini, oxidation of methionine, and cyclization of N-terminal glutamine). Up
to two modifications per peptide were allowed, and the enzyme was specified
as trypsin, with one missed cleavage allowed. After homology filtering, we
identified a total of 1,063 and 2,264 proteins in our K562 (LTQ-Orbitrap Velos)
and ESRE (Q Exactive Plus) experiments, respectively, both at a protein
FDR of <0.4%. For details on methods using label-free quantification and
filtering of MS results see SI Materials and Methods.
Western Blot. Western blot analysis was performed as previously described
(31) with antibodies specific for 4EBP1, p-4EBP1Thr37/46, rpS6, p-rpS6Ser235/236,
S6K, p-S6KThr389, PABPC1, PARP, Caspase 3 (cell signaling), β-actin (Sigma),
HNRNP/C, ATIC, RPS3A (Abcam), and SRSF1 (Santa Cruz). Densitometry
analysis was completed using ImageLab (Bio-Rad).
ROS Analysis. ROS was analyzed using the DFCDA Cellular ROS Detection kit
(Abcam) per provided protocol. K562 cells were treated with either H2O2
(250 μM) for a 24-h pretreatment or a 2-h pulse of PBS, OP-Puro (30 μM).
Mock sample was treated with PBS, but without DFCDA reagent. Samples
were analyzed by flow cytometry using BD LSRII.
qPCR Analysis. RNA was isolated using the manufacturer’s protocol for RNA
extraction with TRIzol reagent (Invitrogen) and RNA was DNase-treated with
TURBO DNase (Thermo Fisher). DNase-treated RNA was transcribed to cDNA
(cDNA) with High Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems), and 1 μL cDNA was used to run each SYBR Green detection qPCR
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assay (SYBR Green Supermix and MyiQ2; Bio-Rad). Primers were used at
200 nM. Oligomer sequences were designed to span exon-exon junctions
using Primer Blast and are listed in Fig. S7.
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